✔ Various xenografted models including subcutaneous, orthotopic and disseminated models;
✔ Extensive background on patients’ treatment and molecular/pharmacological characterization;
✔ Corresponding CDX models available;
✔ One-stop platform from animal models to in vivo efficacy studies;
✔ Identification and analysis of biomarkers of in-house PDX models;
✔ PDX models using immunocompromised mice or humanized mice.
https://www.creative-biolabs.com/immuno-oncology/patient-derived-xenografted-models.htm
